General

Thanks to clinical research, the King Albert II Institute offers its patients the latest treatments and we contribute to advancing research in the fight against cancer.60 clinical research protocols are underway at the King Albert II Institute of Cliniques universitaires Saint-Luc.

Clinical research offers patients the opportunity to test new molecules or combinations of molecules before they are put on the market. These are clinical trials proposed by the pharmaceutical industry but also studies initiated by clinicians at the King Albert II Institute. 

The aim of these trials is twofold: on the one hand, to offer patients the most recent treatments, and on the other, to advance research in the fight against cancer.

Thanks to the high number of patients treated in our center and the expertise developed, the King Albert II Institute collaborates with a number of companies. Thus, patients are offered the opportunity to benefit from the latest treatments developed in pharmaceutical laboratories.

These clinical trials are coordinated internally by doctors and medical clinical research coordinators, who are responsible for patient follow-up and data collection.

They are continuously monitored and meet internal and international quality criteria that ensure patient protection and the maintenance of a high standard of medical care.